FDA Panel Backs New COVID Vaccines Aimed at Dominant Strain

(MedPage Today) -- The FDA's vaccine advisors voted 8 to 0, with one abstention, in favor of a monovalent XFG vaccine for COVID-19 shots for the 2026-2027 season. The Vaccines and Related Biological Products Advisory Committee (VRBPAC) also discussed...
Source
MedPage Today
Opens original article in a new tab



